Genomic Health (GHDX) Reports Q4 Loss of $0.01, Beats by 5c; Guides FY10 Sales
Tweet Send to a Friend
Genomic Health, Inc. (NASDAQ: GHDX) reports Q4 loss of $0.01 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
